Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C

Abstract

PEG-IFN α-2b plus RBV treatment was effective in chronic hepatitis C patients 65 years or older who completed treatment with at least the minimum acceptable treatment dosage.